BioAge Labs, Inc.
BIOA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001709941
In the last 90 days, BioAge Labs, Inc. insiders filed 0 open-market purchases and 1 sale; 150 institutions reported holding it in 13F filings for Q2 2026, worth $924.6M in total; no superinvestor holds it.
Superinvestors holding BIOA, Q2 2026
No superinvestor reported holding BIOA in Q2 2026.
Moves by quarter
Superinvestors that opened, added to, trimmed or sold out of BIOA each quarter, comparing shares with the quarter before. A superinvestor that didn't file for a quarter isn't listed, and isn't counted as selling.
Q4 2024
0 superinvestors holding at quarter end
- Sold out
- Soros Fund Management
Q3 2024
1 superinvestor holding at quarter end